NF-kappa-B activation unveils the presence of inflammatory hotspots in human gut xenografts | PLOS ONE
Cells | Free Full-Text | Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases
Major physiological and pathological roles of NF- k B. Numerous studies... | Download Scientific Diagram
NF-kappa-B activation unveils the presence of inflammatory hotspots in human gut xenografts | PLOS ONE
IKK/NF-κB signaling in intestinal epithelial cells controls immune homeostasis in the gut | Mucosal Immunology
NF-κB activation as a pathological mechanism of septic shock and inflammation | American Journal of Physiology-Lung Cellular and Molecular Physiology
Activation of nuclear factor κB in inflammatory bowel disease | Gut
Nuclear Factor κB Signaling in Atherogenesis | Arteriosclerosis, Thrombosis, and Vascular Biology
Frontiers | NF-κB Regulation by Gut Microbiota Decides Homeostasis or Disease Outcome During Ageing
Frontiers | The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances
NF-κB - Wikipedia
Frontiers | The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances
NF-kappa-B activation unveils the presence of inflammatory hotspots in human gut xenografts | PLOS ONE
NF‐κB in inflammatory bowel disease - Atreya - 2008 - Journal of Internal Medicine - Wiley Online Library
An epithelial Nfkb2 pathway exacerbates intestinal inflammation by supplementing latent RelA dimers to the canonical NF-κB module | PNAS
Intestinal non-canonical NFκB signaling shapes the local and systemic immune response | Nature Communications
Frontiers | NF-κB Regulation by Gut Microbiota Decides Homeostasis or Disease Outcome During Ageing
Frontiers | The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances
NF-κB - Wikipedia
Biomolecules | Free Full-Text | NF-kappaB Signaling in Chronic Inflammatory Airway Disease
Cells | Free Full-Text | The Role of NF-κB in Physiological Bone Development and Inflammatory Bone Diseases: Is NF-κB Inhibition “Killing Two Birds with One Stone”?
